Mission Pharmacal launches Ferralet 90 in USA

Mission Pharmacal launched Ferralet 90, a new prescription oral iron supplement for treatment of iron deficiency anemia that is responsive to oral iron therapy, onto the US market. IDA is a depletion of stored iron that prevents maturation of red blood cells. Ferralet 90 contains 90mg of carbonyl iron, as well as essential vitamins and minerals to help patients replenish iron stores in an effective, safe and tolerable manner. Iron deficiency is the most common nutritional deficiency and the leading cause of anemia in the USA.

"If left untreated, IDA has the potential to interfere with the body's vital functions, such as the nervous system, cardiovascular and immune system function. Women of child bearing age are at highest risk of developing iron deficiency anemia, and screening for IDA should be part of every woman's annual medical check up exam," said Miriam Nelson, a health and nutrition expert and author of the best-selling Strong Women book series. "The good news is that new IDA supplements, such as Ferralet 90, that are effective and tolerable can help restore iron levels back into normal range, she added.